Abbott Laboratories (ABT) grew revenue 6.9% with medical devices up 14.8% to $5.45B. Abbott reaffirmed guidance for 7.5-8.0% organic growth. Eli Lilly (LLY) posted 54% revenue growth driven by ...
Early data from first participating employer show that Smart Rx can save organizations millions by bypassing traditional PBMs to deliver brand-name GLP-1 medications NEW YORK, April 23, 2026 (GLOBE ...
Mon, December 8, 2025 at 2:21 PM UTC Abbott's medical device segment grew 14.8% to $5.45 billion. The cardiovascular portfolio drove results, with TriClip for tricuspid valve repair gaining Japan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results